Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: Spekulatius who wrote (19230)	5/20/2004 10:40:06 PM
From: Madharry	Respond to of 78486

actually its precious metals that I own. I guess my point is that while biotech might be risky I am not sure why the current economic or interest rate environment should have any impact on the pricing of such issues. Similarly low price issues may be perceived as more risky than a company like Amazon but who knows. It seems to me that its hard to find companies with assured growth and low pe multiples. Instead of Pfizer how about ICOS? and I forgot to mention STO a norweigian oil company which has declined about 8% despite new highs in oil prices.